Sarafloxacin
Jump to navigation
Jump to search
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATCvet code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H17F2N3O3 |
Molar mass | 385.371 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Sarafloxacin (INN) is a quinolone antibiotic drug,[1][2] which was removed from clinical use by its manufacturer Abbott Laboratories from April 30, 2001.
See also
References
- ^ "Evaluation of certain veterinary drug residues in food. Fiftieth report of the joint FAO/WHO Expert Committee on Food Additives". World Health Organization Technical Report Series. 888: i–vii, 1–95. 1999. PMID 10416362.
- ^ Gingerich WH, Stehly GR, Clark KJ, Hayton WL (1998). "Crop grouping: a proposal for public aquaculture". Veterinary and Human Toxicology. 40 (Suppl 2): 24–31. PMID 9823579.
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed CASNo identifier
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Fluoroquinolone antibiotics
- 1,4-di-hydro-7-(1-piperazinyl)-4-oxo-3-quinolinecarboxylic acids
- 1-Piperazinyl compounds
- All stub articles
- Antibiotic stubs